Presence of the bcl-2 protein and apoptosis in non-hodgkin lymphomas with diffuse growth pattern
- 9 June 1995
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 61 (6) , 826-831
- https://doi.org/10.1002/ijc.2910610614
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival timeBritish Journal of Cancer, 1994
- Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sectionsThe Journal of Pathology, 1993
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- In situ end‐labelling detects DNA strand breaks in apoptosis and other physiological and pathological statesThe Journal of Pathology, 1993
- Apoptotic Index: Discriminant Feature for the Differentiation of Cutaneous Diffuse Malignant Follicular Center Cell Lymphomas from Lymphoid HyperplasiaJournal of Investigative Dermatology, 1993
- Thymocyte apoptosis induced by p53-dependent and independent pathwaysNature, 1993
- Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphomaBritish Journal of Cancer, 1992
- Diffuse centrocytic and/or centroblastic malignant non‐hodgkin's lymphomas: Comparison of mitotic and pyknotic (apoptotic) indicesInternational Journal of Cancer, 1991
- Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell deathNature, 1990
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982